|
|
Volumn 13, Issue 5, 1996, Pages
|
|
Importance of oral antimetabolite "maintenance" therapy in childhood lymphoblastic leukemia.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
MERCAPTOPURINE;
METHOTREXATE;
ACUTE LYMPHOCYTIC LEUKEMIA;
BLOOD;
CHILD;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG DETOXIFICATION;
HUMAN;
INTESTINE ABSORPTION;
NOTE;
ORAL DRUG ADMINISTRATION;
PATIENT COMPLIANCE;
PSYCHOLOGICAL ASPECT;
STATISTICS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
6-MERCAPTOPURINE;
ADMINISTRATION, ORAL;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHILD;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
INTESTINAL ABSORPTION;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
METABOLIC DETOXICATION, DRUG;
METHOTREXATE;
PATIENT COMPLIANCE;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
|
EID: 0030222956
PISSN: 08880018
EISSN: None
Source Type: Journal
DOI: 10.3109/08880019609030848 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
